Investors

Charter Life Sciences (CLS)

Charter Life Sciences (CLS) is an early stage life sciences venture capital investor. CLS invests in early stage companies that are developing emerging products and technologies that address a significant unmet clinical need within a large and growing market segment. CLS typically leads and makes its initial investment in a company’s first round of institutional financing. After investment, CLS provides continuing strategic and financial support through each phase of our portfolio company’s development.